Frank Harvey, CEO of Surescripts, recently spoke with Healthcare Innovation about a range of issues, including a recent acquisition, the potential for pharmacists to play a larger role on primary care teams, and why Surescripts Health Information Network LLC is applying to become a Qualified Health Information Network (QHIN) under the Trusted Exchange Framework and Common Agreement (TEFCA). Harvey succeeded Tom Skelton as CEO in 2022. A pharmacist himself, Harvey has held leadership positions in the healthcare technology, pharmacy and pharmaceutical sectors. He joined Surescripts from ATLS Investments LLC, where he led private equity investing in healthcare technology companies.
Read the full article: Q&A: Surescripts CEO Frank Harvey //